Sara Shanti is a partner in the Corporate Practice Group in Sheppard Mullin’s Chicago office. Sara’s practice sits on the cutting-edge of health-tech, providing practical counsel to clients building novel innovation in healthcare and to clients’ complex data privacy matters. Sara represents a broad range to clients, including providers, payors, and technology companies, in healthcare regulatory compliance matters related to Next-Gen technology, including artificial intelligence and machine learning (AI/ML), augmented and virtual reality (AR/VR) and metaverses, implantable and wearable devices, innovation centers, and telehealth. Prior to private practice, Sara worked for the U.S. Department of Health and Human Services, Office for Civil Rights.
Arushi Pandya is an associate in the Governmental Practice in Sheppard Mullin’s Washington, D.C. office, and a member of the Healthcare and FDA Regulatory industry teams. Arushi advises healthcare and life sciences clients on a variety of regulatory compliance matters, including data privacy, telemedicine and digital health, fraud and abuse, licensure, scope of practice, and pre- and post-market FDA requirements for drugs and devices. She interned at St. Jude Children’s Hospital, the American Health Law Association, and Decent, Inc. during her time in law school. Arushi received her J.D. as well as her B.S.A. in Biology and B.A. in Plan II Honors from the University of Texas at Austin.
Elizabeth Nevins is an associate in the Corporate Practice Group in Sheppard Mullin’s Dallas office. Elizabeth earned her J.D. from SMU Dedman School of Law in Dallas, Texas, where she graduated with honors. During law school, she served as an Articles Editor for the SMU Law Review, was named a Tsai Scholar for the Tsai Center for Law, Science and Innovation, volunteered for the COVID-19 legal helpline, and worked as a research assistant studying the intricacies of bioethics, healthcare regulation, and health inequities. She received a B.S. in Biomedical Sciences with a minor in Spanish from Texas A&M University, where she also graduated with honors. Prior to law school, Elizabeth worked at UT Southwestern Medical Center in the Biochemistry department as a research technician utilizing genetic modification techniques to help study metabolic processes and discover pro-neurogenic chemicals to tackle neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS.
Although there is uncertainty and risk, the implementation of AI with the right compliance framework and infrastructure offers an exciting opportunity to transform healthcare into a new frontier with improved patient outcomes and increased efficiency.